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Abstract
Background: Sonic hedgehog (Shh) signaling regulates cell proliferation during vertebrate development via induction of
cell-cycle regulator gene expression or activation of other signalling pathways, prevents cell death by an as yet unclear
mechanism and is required for differentiation of retinal cell types. Thus, an unsolved question is how the same signalling
molecule can regulate such distinct cell processes as proliferation, cell survival and differentiation.
Methodology/Principal Findings: Analysis of the zebrafish shh
2/2 mutant revealed that in this context p53 mediates
elevated apoptosis during nervous system and retina development and interferes with retinal proliferation and
differentiation. While in shh
2/2 mutants there is activation of p53 target genes and p53-mediated apoptosis, an increase
in Hedgehog (Hh) signalling by over-expression of dominant-negative Protein Kinase A strongly decreased p53 target gene
expression and apoptosis levels in shh
2/2 mutants. Using a novel p53 reporter transgene, I confirm that p53 is active in
tissues that require Shh for cell survival. Proliferation assays revealed that loss of p53 can rescue normal cell-cycle exit and
the mitotic indices in the shh
2/2 mutant retina at 24, 36 and 48 hpf. Moreover, generation of amacrine cells and
photoreceptors was strongly enhanced in the double p53
2/2shh
2/2 mutant retina suggesting the effect of p53 on retinal
differentiation.
Conclusions: Loss of Shh signalling leads to the p53-dependent apoptosis in the developing nervous system and retina.
Moreover, Shh-mediated control of p53 activity is required for proliferation and cell cycle exit of retinal cells as well as
differentiation of amacrine cells and photoreceptors.
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Introduction
During organogenesis, cell numbers are tightly controlled by
balancing proliferation and cell death. Hh signaling pathway
regulates cell proliferation and survival during development in
addition to its pattern formation and differentiation functions in
many different biological contexts (reviewed in [1,2,3]). Work from
many labs has shown that secreted Hh proteins bind to the
transmembrane protein Patched (Ptc) and release the inhibition of
the transmembrane protein Smoothened (Smo) by Ptc. The signal
transduction downstream of Smo inhibits proteolytic processing of
Gli2 and Gli3 to repressive forms, which is mediated by Protein
Kinase A (PKA) and a few other factors [4]. The resulting full-
length Gli factors can activate their target genes.
Shh is an essential survival factor for many cell types during
development such as neural stem cells [5], cells in the neural tube
[6,7,8], midbrain and forebrain [9], neural crest [10,11], retina
[12], and ventral sclerotome [7]. These findings are supported by
the fact that restoring Shh signalling can suppress apoptosis [6,8].
Interestingly, in the neural tube Shh signalling promotes cell
survival before its requirement for tissue patterning and differen-
tiation [13] arguing against the hypothesis that Shh prevents cell
death by providing patterning cues.
Nevertheless, there is still some controversy about the under-
lying mechanism of the anti-apoptotic role of Shh. Activation of
anti-apoptotic genes by Shh signaling is the simplest scenario, and
indeed, Gli1 can activate BCL2 gene expression in human cell
lines and in the mouse keratinocytes by binding to several near-
consensus sites in the BCL2 promoter [14]. Likewise, over-
expression of the Gli3 dominant-active form in developing chick
embryos leads to induction of Bcl2 gene [13]. Moreover, another
study has proposed that in the absence of Shh, Patched1 mediates
apoptosis in the neural tube through caspase activation indepen-
dent of the canonical Shh signaling pathway [15]. Patched1 could
function in this context as a dependency receptor, i.e. a receptor
inducing cell death in the absence of cognate ligand binding
[16,17]. Recently, Abe and colleagues (2008) have shown that
activation of Hh signaling can suppress p53 pathway in human cell
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13549lines [18]. The authors have proposed that Hh signaling induces
an unknown Mdm2- activating factor leading to phosphorylation
of serines 166 and 186 on Hdm2 (human Mdm2), which becomes
activated and catalyses ubiquitination of p53. Degradation of
ubiquitinated p53 disrupts p53-mediated tumour suppression
under conditions of DNA damage and oncogenic stress.
Furthermore, Stecca and Ruiz i Altaba (2009) have described a
negative feedback loop between p53 and Gli1 in transgenic mouse
models [19]. The authors found that p53 inhibits activity of Gli1
by interfering with its normal nuclear localization and directing it
to proteosomal degradation. Closing the loop, Gli1 overexpression
leads to a striking increase of Mdm2 expression and down-
regulation of p53 in the mouse brain and several cell lines.
Beside this anti-apoptotic function, Shh is also known to
stimulate proliferation by direct regulation of cell-cycle promoting
genes or through activation of secondary signaling pathways.
In particular, Hh ligands stimulate proliferation in the mouse
skin [20], in the vertebrate central nervous system [13,21,22,
23,24,25], and in Drosophila wing [26,27] and eye imaginal discs
[28]. In the vertebrate retina, Shh stimulates proliferation of
retinal progenitors in vitro [29,30] and in the ciliary marginal zone
[31]. Moreover, during mouse retina development Shh-mediated
activation of cyclinD1 expression is essential for proliferation and
cell-cycle exit of retinal ganglion cell progenitors [32]. Consistent
with this, in the zebrafish shh
2/2 mutant retina, proliferation is
reduced during neurogenesis [12]. In Xenopus, Shh signalling has
been shown to promote retinal progenitor proliferation by
activating expression of cell cycle regulators, which shortens G1-
and G2-phases of the cell cycle, and thereby drives cells towards
the final mitosis and cell-cycle exit [33]. Interestingly, in several
other contexts Hh signalling has been shown to negatively regulate
cell cycle progression [34]. Indeed, in zebrafish shh
2/2 mutant
retina and after Hh signaling inhibition by forskolin, most retinal
cells fail to express p57Kip2 cyclin-dependent kinase (CDK)
inhibitor and do not exit the cell cycle [35,36].
This study shows that loss of shh in zebrafish leads to p53-
mediated apoptosis in the developing nervous system and retina.
Consistent with this, activation of Hh signalling suppresses p53
activity and apoptosis in the shh
2/2 mutant. To monitor p53
activation, I created a p53 reporter transgenic line expressing
nuclear green fluorescent protein under control of p53-sensitive
promoter, verified by p53 knock-down and being induced by
roscovitine treatment. By using this line, I have determined the
spatio-temporal activation of p53 and apoptosis in the shh
2/2
mutant. Further, comparisons of double p53
2/2shh
2/2 mutants
with wild-type, and shh
2/2 mutant embryos identified p53-
mediated inhibition of retinal progenitor proliferation, cell-cycle
exit and differentiation of amacrine cells and photoreceptors.
Taken together, these data provide novel genetic evidence that
Shh regulates cell survival during nervous system and retina
development as well as retinal proliferation and differentiation
through inhibition of p53 pathway.
Results
p53 mediates apoptosis in shh
2/2 mutant via the
intrinsic apoptotic pathway
To determine the mechanism of cell death due to loss of shh,I
analysed the expression of anti-apoptotic Bcl-2 family genes bcl2,
bcl2l, mcl1a and mcl1b in shh
2/2 mutant and wild-type embryos,
their expression being comparable in embryos of both genotypes
at 24 hours post fertilization (hpf) (Fig. S1). I next looked at the
expression of p53-dependent genes by in situ hybridisations which
revealed consistently stronger expression of p53 target genes p53,
cyclinG1, bax1, puma and p21 at 24 hpf in the neural tube, retina
and somites of shh
2/2 mutant relative to wild-type embryos
(Fig. 1A) and elevated expression of p53 at 56 hpf in the shh
2/2
mutant retina, midbrain and branchial arches (Fig. 1B). The
observed elevated p53 expression was due to induction of the short
D113 p53 transcript isoform [37,38] in the shh
2/2 mutant,
whereas the level of the full-length p53 transcript was comparable
between shh
2/2 mutant and wild-type embryos (Fig. 1C). To
better measure p53 target gene expression levels, I performed
quantitative polymerase chain reaction (qPCR) analyses on shh
2/2
mutant versus wild-type embryos at 24 hpf and 56 hpf confirming
elevated expression of p53, p21 mdm2, cycG1, bax1 and puma in
shh
2/2 mutants at both stages (Fig. 1D, E). The pro-apoptotic
genes bax1 and puma, but not noxa, showed higher expression in
shh
2/2 mutants compared to wild-type embryos at both 24 hpf
(Fig. 1D) and 56 hpf (Fig. 1E), the relative expression of puma, the
most potent inducer of mitochondrial apoptosis [39,40], being
higher in shh
2/2 mutant embryos at 24 hpf (Fig. 1D) than at 56
hpf (Fig. 1E) correlating with a higher level of apoptosis at 24 hpf
(Fig. 2).
To confirm that p53 is essential for elevated apoptosis in the
shh
2/2 mutant, I used morpholino oligonucleotides (MO) [41]
knock-down against p53 previously shown to effectively block p53
translation during zebrafish development [42]. Injection of p53
MO but not of 4-mismatch control MO into the shh
2/2 mutant
embryos suppressed elevated apoptosis in the neural tube at 24 hpf
(Fig. 2A) as confirmed using image quantification of apoptosis
stainings (Fig. 2A’) and in the retina at 56 hpf (Fig. 2C). Apoptosis
can occur through either extrinsic pathway when cells receive
external signals activating death receptors or intrinsic (mitochon-
drial) pathway when pro-apoptotic factors are released from
mitochondria after their permeabilization, p53 activating primar-
ily the intrinsic rather than the extrinsic apoptotic pathway [43].
To test whether p53 activates the mitochondrial pathway of
apoptosis in the shh
2/2 mutant, I injected mRNA of EGFP-bcl2,
an inhibitor of the mitochondrial apoptotic pathway, or EGFP
into shh
2/2 mutant and wild-type embryos. Expression of EGFP-
bcl2 significantly reduced the level of apoptosis in shh
2/2 mutants
at 24 hpf, whereas EGFP did not have any effect (Fig. 2B, B’)
suggesting that the p53-mediated apoptosis in the shh
2/2 mutant
occurs via the intrinsic pathway.
p53-dependent apoptosis in the shh
2/2 mutant retina
To determine if genetic loss of p53 can rescue excessive
apoptosis in the shh
2/2 mutant, p53
2/2shh
2/2 double mutant
animals were generated using the previously published tp53
M214K
mutant zebrafish [44]. Indeed, high level of apoptosis in the shh
2/2
mutants at 24 hpf (Fig. 3A-b) and in the retina at 72 hpf (Fig. 3B-
b) compared to wild-type (Fig. 3A-a, 3B-a) was reduced in the
p53
2/2shh
2/2 mutant (Fig. 3A-c) to the wild-type level (Fig. 3A-c,
3B-c). I further examined differentiation status of apoptotic cells in
the wild-type and shh
2/2 mutant retinas at 72 hpf by staining cells
for neuronal marker HuC and apoptotic cells using TdT-mediated
dUTP-biotin nick end labelling (TUNEL). In the wild-type retina,
both HU-positive and negative apoptotic were present (Fig. 3C-a).
By contrast, most apoptotic cells in the shh
2/2 mutant retina were
undifferentiated (HuC-negative) (Fig. 3C-b), but some were HU-
positive (Fig. 3C-b) suggesting that differentiating cells also die by
apoptosis in the shh
2/2 mutant retina.
PG13p21::nlsEGFP, a p53 reporter in the living zebrafish
embryos
To study the behaviour and characteristics of cells which have
undergone activation of p53, I constructed a transgenic reporter to
p53 Activation in shh Mutant
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2/2 mutant. (A) 24 hpf wild-type and shh
2/2 mutant embryos were in situ
hybridised with probes against p53, cyclinG1, bax1, puma and p21 mRNAs. These p53 target genes are expressed at a higher level in the shh
2/2
mutant in neural tube, retina and somites than in wild-type embryos. (B) 56 hpf wild-type and shh
2/2 mutant embryos were hybridized with the
probe against p53 mRNA. The hybridizations show increased expression of p53 in shh
2/2 mutant compared to wild-type embryos in the brain, retina
and branchial arches. The following structures are labelled: retina, midbrain (mb) and branchial arches (ba). (C) p53 transcript isoforms in shh
2/2
mutant and wild-type at 24 and 56 hpf were analysed by semi-quantitative PCR assays for full-length p53, D113 p53 transcripts and b-actin transcript
as a loading control. At both stages, full-length p53 and b-actin transcripts were expressed at similar levels in wild-type and mutant samples, whereas
D113 p53 was strongly upregulated in shh
2/2 mutant samples. (D, E) qPCR assays for p53, p21, mdm2, cyclinG1, bax1, puma, noxa and gapdh were
performed at 24 hpf (D) and 56 hpf (E) on wild-type and shh
2/2 mutant embryos. cDNA from whole embryos was used for 24 hpf samples and cDNA
from embryo heads was used for 56 hpf samples. Gene expression was normalized using gapdh expression as reference. The panels show p53 target
gene expression in wild-type and shh
2/2 mutant embryos (D, E). Error bars represent standard deviation and an asterisk indicates statistical
significance. There are significant expression differences between wild-type and shh
2/2 mutant samples (t-test, * - p,0.05) for all genes except noxa.
qPCR assays were performed in triplicates on three different clutches of embryos and standard deviations are shown.
doi:10.1371/journal.pone.0013549.g001
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construct a p53 reporter in human cell lines [45]. A 2,4 kb
promoter fragment of human CDKN1A encoding p21 CDK
inhibitor and 13 copies of the optimal p53 binding site (PG13) [46]
were combined into a p53-sensitive promoter. Tol2kit transgenic
system [47] was then used to assemble the final construct
containing PG13p21 promoter, nlsEGFP coding sequence and a
polyA signal (Fig. 4A).
Figure 2. Knock-down of p53 suppresses apoptosis in the shh
2/2 mutant mediated by the intrinsic apoptosis pathway. (A) Apoptosis
labelling using ApopTag staining in wild-type and shh
2/2 mutant embryos at 24 hpf after injection of p53 morpholino or control morpholino. The
whole-mount images of the head (head) and neural tube (nt) are shown. (A’) Quantification of ApopTag signal area in wild-type and shh
2/2 mutant
embryo head images from (A) shows that p53MO successfully decreased apoptosis in shh
2/2 mutant to the wild-type level. Asterisks (***) on top of
the shh
2/2 mutant bar indicate its significant statistical differences from other samples (t-test, P-value,0,001). (B) Apoptosis labelling using ApopTag
staining in wild-type and shh
2/2 mutant embryos at 24 hpf after injection of of EGFP-bcl2 or EGFP mRNA. The whole-mount images of the head
(head) and neural tube (nt) are shown. (B’) Quantification of ApopTag signal area in wild-type and shh
2/2 mutant embryo head images from (B)
shows that EGFP-bcl2 successfully decreased apoptosis in shh
2/2 mutant to the wild-type level. Asterisks (***) on top of the shh
2/2 mutant bar
indicate its significant statistical differences from other samples (t-test, P-value,0,001). (C) Retinal apoptosis observed in shh
2/2 mutant at 56 hpf was
suppressed by injection of p53 morpholino but not by injection of control morpholino (n=10 and 40 sections for shh
2/2 mutant injected with p53
morpholino; n=10 and 34 sections for shh
2/2 mutant injected with control morpholino). *** - t-test, P-value,0,001.
doi:10.1371/journal.pone.0013549.g002
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p53 activation and regulation. Studies of p53 in zebrafish employed
camptothecin, a genotoxic drug, or roscovitine, a CDK inhibitor, to
induce p53-dependent apoptosis [42,48]. To verify that p53 reporter
line can be used as a bona fide p53 reporter in vivo, I have treated p53
reporter transgenic fish with roscovitin. Wild-type embryos carrying
the p53 reporter transgene were incubated either with 50 mM
roscovitine or 0.4% DMSO as a control for 6 hours starting at 24 hpf.
p53 reporter expression was strongly up-regulated in the brain and
retina of roscovitine-treated but not in control DMSO-treated
embryos (Fig. 4B). Furthermore, knocking down p53 with morpho-
lino in shh
2/2 mutant strongly inhibited expression of p53 reporter
t r a n s g e n ea t2 4h p f( F i g .4 C ) .M o r e o v e r ,i nt h eshh
2/2 mutant retina
at 56 hpf, most apoptotic cells showed co-localisation of active
Caspase3 labeling with p53 reporter nlsEGFP in the cytoplasm
(Fig. 4D) suggesting that apoptosis is induced in cells with active p53.
Co-localised pixels made 20,9 +/2 3,8% of total active Caspase 3
pixels, but only 11,7 +/2 4,5% of total p53 reporter nlsEGFP pixels,
the difference being significant (t-test, P-value,0,001), (Fig. 4E)
suggesting that apoptotic cells expressing p53 reporter are more
frequent than p53 reporter-positive cells undergoing apoptosis,
consistent with p53 activating caspases as a downstream result of its
activity.
Expression of p53 reporter in tissues requiring Shh for
survival
I have analysed p53 reporter expression at 24 hpf and 56 hpf in
theshh
2/2 mutant andwild-typeembryos(Fig.5).At24 hpf, shh
2/2
mutants expressed much higher level of nlsEGFP and contained
many more TUNEL-positive cells in midbrain, hindbrain and
spinal cord than wild-type embryos (Fig. 5B, C, D). I also detected
that at 56 hpf shh
2/2 mutant hindbrain expressed the p53 reporter
at a higher level than wild-type embryos (Fig. 5F). By contrast,
shh
2/2 mutant retina showed strong expression of the p53 reporter
but no elevated apoptosis at 24 hpf (Fig. 5A). This result is
interesting and unexpected asshh expressionstartsintheretina at28
hpf [49]. However, at 56 hpf in the shh
2/2 mutant retina, both p53
reporter expression and number of TUNEL-positive cells are high
compared to wild-type(Fig. 5E).Activation of p53inshh
2/2 mutant
retinal cells before 28 hpf indicates that they require Shh signalling
at an earlier stage to control p53 activity. In the absence of Shh,
neural crest cells undergo apoptosis [10] and indeed some p53
reporter positive cells present in the midbrain arelocated in a region
populated by neural crest cells (Fig. 5B). p53 reporter also labeled
somitecells(Fig.5D),which arelikelysclerotomecells requiring Shh
for their survival [7].
Hh signalling activation by dnPKA-GFP decreases
cyclinG1 expression and apoptosis in shh
2/2 mutant
embryos at 12-somite stage
In tissue culture experiments, p53 activation has been shown to
be inhibited by Gli-mediated activation of an unknown p53
pathway inhibitor [18]. This leads to the question whether
activation of Hh signalling inhibits p53 pathway in vivo in the
absence of Shh. To activate the canonical Hh/Gli signaling
Figure 3. Genetic loss of p53 suppresses apoptosis in the shh
2/2 mutant. Apoptosis was assayed in whole-mount embryos using ApopTag (A,
a–c) and on retinal sections using TUNEL labelling (B, a–c). The sections are oriented with their anterior side to the top. Elevated apoptosis in shh
2/2
mutant embryos compared to wild-type embryos was suppressed by p53 loss in the developing nervous system (A, a–c) and in the retina (B, a–c). (A)
Whole-mount ApopTag staining at 24 hpf of wild-type, shh
2/2 and p53
2/2shh
2/2 embryos (a–c). (B) TUNEL/DAPI staining of retinal sections of wild-type,
shh
2/2 and p53
2/2shh
2/2 embryos at 72hpf (a–c). (C) Wild-type (a) and shh
2/2 mutant(b) retinal cryosectionsfrom 72hpf embryos stained withanti-HU
antibodies to detect retinal neurons and TUNEL to label apoptotic cells. Cells positive for both HU and TUNEL are indicated with arrows and cells positive
only for TUNEL are labelled with arrowheads. Images were obtained from retinal sections of 10 embryos and representative overlay images are shown.
doi:10.1371/journal.pone.0013549.g003
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GFP (dnPKA-GFP) [50,51] or EGFP mRNA as a control into
progeny of fish heterozygous for the shh deletion. Given the limited
mRNA stability, I analysed the effects of RNA injections at the 12
somites stage, when shh
2/2 mutant embryos already show a higher
level of p53 target gene expression and apoptosis than wild-type
embryos (Fig. S2). While all the EGFP-injected embryos showed
unaltered wild-type or shh
2/2 mutant patched1 expression pattern
(Fig. 6A, D, ‘‘low’’), over-expression of dnPKA-GFP led to ectopic
spreading of patched1 expression in 87,7 +/2 3,8% of embryos
(Fig. 6A, D, ‘‘high’’). I next assessed expression of cyclinG1, p53
target gene, after mRNA injections by visually scoring expression
strength as ‘‘high’’ or ‘‘low’’ based on staining of uninjected
embryos (Fig. 6B), where embryos with ‘‘high’’ cyclinG1 expression
were inferred to be shh
2/2 mutant and those with ‘‘low’’
expression were wild-type (control stainings of wild-type embryos,
not shown). In this experiment, the effect of dnPKA-GFP on p53
target gene expression is inferred from the change in proportion of
embryos with stronger cyclinG1 expression. While after EGFP
mRNA injection the proportion of embryos with ‘‘high’’
expression of cyclinG1 was 25,3 +/2 1,2% (Fig. 6D), only 6 +/2
2% (Fig. 6D) of dnPKA-GFP -injected embryos had perceptibly
stronger cyclinG1 expression than the other embryos in the samples
(Fig. 6D). Overexpression of dnPKA-GFP also reduced the
proportion of embryos with higher apoptosis levels (Fig. 6C) to
5,8 +/2 2,4% (Fig. 6D) (Fig. 6D) compared to 24,7 +/2 1,53%
(Fig. 6D) among EGFP-injected embryos (Fig. 6D). Taken
together, these data indicate that activation of Hh signalling using
dnPKA-GFP can suppress p53 target expression and apoptosis.
p53 regulates the mitotic indices in the shh
2/2 mutant
retina
To determine the effect of p53 loss on proliferation in the
absence of Shh, I quantified mitotic cells in the wild-type, p53
2/2,
shh
2/2 and p53
2/2shh
2/2 mutant retinas at 24, 34 and 48 hpf
stages by staining retinal sections for Ser10-phosphorylated form
Figure 4. Zebrafish p53 reporter line construction and verification. (A) p53 reporter PG13p21::nlsEGFP-polyA was constructed using Tol2kit
as described in Materials and methods. It consists of the p21 promoter fused with p53-binding enhancer sequence PG13, nlsEGFP coding sequence
and a polyadenylation signal (polyA). (B) Wild-type embryos carrying the p53 reporter transgene were incubated for 6 hours at 24 hpf with either
50 mM Roscovitine or 0.4% DMSO diluted in E3 medium. DMSO-treated embryos did not show any significant expression of the reporter (right),
whereas roscovitine-treated ones expressed p53 reporter at a high level (left). All embryos showed green-heart transgenesis marker. The experiment
was repeated three times and 20 embryos were used for each treatment. (C) p53 morpholino but not 4-mismatch control morpholino injection
suppressed expression of PG13p21::nlsEGFP p53 reporter in shh
2/2 mutant embryos at 24 hpf. Both injections had no effect on p53 reporter
expression in the wild-type embryos. (D) Anti-active Caspase3 staining of cells in the shh
2/2 mutant retina at 56 hpf expressing p53 reporter
transgene PG13p21::nlsEGFP. Most cells positive for active Caspase3 also expressed p53 reporter transgene. Single channel, overlay and co-
localisation analysis images are shown. (E) Quantification of co-localisation of active Caspase3 staining and nlsEGFP p53 reporter signal. Co-localised
pixels made up 20,9 +/2 3,8% of total active Caspase3 pixels and 11,7 +/2 4,5% of total nlsEGFP pixels. Quantifications were performed on 20 retinal
section images from 10 embryos. Asterisks (***) indicate a significant statistical difference between the proportions (t-test, P-value,0,001).
doi:10.1371/journal.pone.0013549.g004
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mitosis [52]. At 24 hpf, retinal cells in zebrafish are highly
proliferative and are not exiting the cell cycle, while at 34 and 48
hpf, retinal cells are exiting the cell cycle and acquire terminal
fates. Analysis of how p53 affects proliferation in the shh
2/2
mutant retina at 24 hpf and during neurogenesis will shed light on
the role of p53 in early progenitor proliferation and their cell cycle
exit. Retinal mitotic indices at 24 hpf in wild-type (14,9 +/2 2,4%)
(Mean +/2 standard deviation), p53
2/2 (15,3 +/2 2,4%) and
p53
2/2shh
2/2 (13,1 +/2 1,9%) were pairwise not significantly
Figure 5. Expression of p53 reporter and apoptosis are strongly elevated in the shh
2/2 mutant embryos. Wild-type and shh
2/2 embryos
at 24hpf (A–D) and 56 hpf (E, F) carrying p53 reporter transgene (PG13p21::nlsEGFP) were transversally sectioned, nuclei were stained with DAPI and
apoptotic cells – with TUNEL, nlsEGFP signal is endogeneous (A–F). The developing nervous system of shh
2/2 mutant embryos showed high level of
p53 reporter expression and apoptosis compared to wild-type embryos at both 24 (B–D) and 56 hpf (F). (A) At 24 hpf, p53 reporter was strongly
induced in the shh
2/2 mutant compared to the wild-type retina, but there was no elevated apoptosis in the shh
2/2 mutant retina. (B) Expression of
p53 reporter and TUNEL labeling in midbrain of shh
2/2 mutant and wild-type embryos at 24 hpf. (C) Expression of p53 reporter and TUNEL labeling in
hindbrain of shh
2/2 mutant and wild-type embryos at 24 hpf. (D) Expression of p53 reporter and TUNEL labelling in spinal cord of shh
2/2 and wild-
type at 24 hpf. (E) At 56 hpf, both p53 reporter expression and apoptosis were much higher in the shh
2/2 retina than in the wild-type retina. (F)
Expression of p53 reporter and TUNEL labelling in hindbrain regions of shh
2/2 and wild-type embryos at 56 hpf.
doi:10.1371/journal.pone.0013549.g005
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PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13549Figure 6. Hh signaling activation by dnPKA-GFP decreases p53 target cyclinG1 expression and suppresses apoptosis in shh
2/2 mutant
embryos. Embryos from shh
+/– parent fish were injected with either dnPKA-GFP or EGFP mRNA, grown to 12-somite stage and in situ stained for
patched1, target gene of Hh signaling, and cyclinG1, p53 target gene, and ApopTag staining was performed to characterize the level of apoptosis. (A)
Injection of dnPKA-GFP led to a strongly increased and more widely spread expression of patched1 (category ‘‘high’’) in 87,7+/23,8% of injected
embryos, the rest having normal wild-type or low shh
2/2 mutant patched1 expression comparable to expression of patched1 in EGFP-injected embryos
from shh
+/– parent fish (category ‘‘low’’). (B) Expression of cyclinG1 in uninjected embryos from shh
+/– parent fish. Categories ‘‘high’’ and ‘‘low’’ indicate
expression levels in shh
2/2 mutant and wild-type embryos, respectively. (C) ApopTag staining of apoptotic cells in uninjected embryos from shh
+/–
parent fish. Categories ‘‘high’’ and ‘‘low’’ indicate levels of apoptosis in shh
2/2 mutant and wild-type embryos, respectively. (D) Statistical analysis of
results from injections of dnPKA-GFP and EGFP mRNA into embryos from shh
+/– parent fish. All of EGFP-injected embryos had ‘‘low’’ expression of
patched1,2 5 , 3+/2 1,15% (Mean +/2 standard deviation) of them had ‘‘high’’ expression of cyclinG1 and 24,7 +/2 1,53% had ‘‘high’’ apoptosis levels.
dnPKA-GFPmRNAinjectionledto‘‘high’’expressionofpatched1in87,7+/23,8%ofembryosanddecreasedexpressionofcyclinG1andapoptosislevels:
‘‘high’’ proportions are 6 +/2 2% and 5,8 +/2 2,4%, respectively. The experiment was done 3 times and 60 embryos were used for each staining.
Asterisks (***) on top of shh
2/2 mutant bars indicate significant statistical differences of proportions (Fisher’s exact test, P-value,0,001).
doi:10.1371/journal.pone.0013549.g006
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index of shh
2/2 mutant (7,5 +/2 2,3%) (Fig. 7A, D), suggesting
that p53 loss rescues early retinal progenitor proliferation to a
nearly normal level. At both 34 and 48 hpf, I found much fewer
mitotic cells in the shh
2/2 mutant than in the wild-type retina
(Fig. 7B, C). Strikingly, the p53
2/2shh
2/2 mutant retina contained
more mitotic cells and was larger than the shh
2/2 mutant retina at
both 34 and 48 hpf (Fig. 7B, C). At 34 hpf, mitotic indices in the
wild-type retina (11,8 +/2 1,73%) and in the p53
2/2 mutant
retina (12 +/2 1,46%) were not statistically different (t-test,
P=0,67) suggesting that p53 loss alone does not increase the
mitotic index (Fig. 7E). By contrast, the mitotic index in the shh
2/2
mutant retina (7 +/2 1,38%) was significantly lower than in the
wild-type retina or in the p53
2/2shh
2/2 retina (12,1 +/2 1,9%) (t-
test, P,0,001) (Fig. 7E), not different from the wild-type mitotic
index (t-test, P=0,55) (Fig. 7E). At 48 hpf, the mitotic indices in
the wild-type (11,1 +/2 2%) and shh
2/2 mutant (7,16 +/2
1,25%) retinas were significantly different (t-test, P,0,001)
(Fig. 7F), and there was no difference between mitotic indices of
the p53
2/2shh
2/2 mutant retina (11,6 +/2 1,54%) and the wild-
type retina (t-test, P= 0,34) (Fig. 7F). Thus, the results at 24, 34
and 48 hpf conclusively demonstrate that p53 decreases mitotic
indices in the shh
2/2 mutant retina during early retinal progenitor
proliferation and neurogenesis.
p53 inhibits cell-cycle exit in the shh
2/2 mutant retina
The normal mitotic index during neurogenesis in the p53
2/2
shh
2/2 retina could result from the rescue of cell-cycle exit of
retinal progenitors by p53 loss. On the other hand, failure of cell-
cycle exit could activate p53, even though p53 activation occurs
much earlier than cell-cycle exit in the shh
2/2 mutant retina
(Figs. 5, S2). To distinguish between these scenarios, I directly
analyzed cell-cycle exit progression using one-hour 5-bromo-
deoxyuridine (BrdU) incorporation in the wild-type, shh
2/2 and
p53
2/2shh
2/2 mutant retinas at 48 and 56 hpf stages, when cell-
cycle exit in the retina is being completed, with subsequent
quantification of BrdU-positive cells using 49,6-Diamidino-2-
phenylindol (DAPI) staining. At 49 hpf, the proportion of BrdU-
positive cells in the shh
2/2 retina (53,8 +/2 7%) was significantly
higher (t-test, P-value,0,001) than in either the wild-type
(34,1 +/2 4,4%) or p53
2/2shh
2/2 retinas (39 +/2 2,8%), the
difference between wild-type and p53
2/2shh
2/2 BrdU-positive
proportions still being significant (t-test, P-value,0,01) (Figs. 8A,
D), suggesting a slight delay of cell-cycle exit in the p53
2/2shh
2/2
retina compared to wild-type. By 57 hpf, cell-cycle exit in the
retina progressed decreasing the proportions of BrdU-positive cells
in wild-type (17,1 +/2 1,3%) and p53
2/2shh
2/2 (19 +/2 2,8%)
embryos, which were both significantly lower than in the shh
2/2
retina (55,8 +/2 5%) (t-test, P-value,0,001). Interestingly, at 57
hpf BrdU the proportions of BrdU-positive cells in wild-type and
p53
2/2shh
2/2 retinas were not different (t-test, P-value.0,05),
suggesting a complete rescue of cell-cycle exit in the shh
2/2 retina
by p53 loss.
I then addressed the hypothesis that p53 loss in the shh
2/2
retina induces expression of p57kip2, a cyclin-dependent kinase
inhibitor essential for cell-cycle exit in the zebrafish retina. Indeed,
at 38 hpf, p57kip2 was expressed in large areas of wild-type and
p53
2/2shh
2/2 mutant retinas, but absent from the shh
2/2 mutant
retina (Fig. 8C), whereas p53 was much more strongly expressed in
the shh
2/2 mutant retina than in the wild-type and p53
2/2shh
2/2
mutant retinas (Fig. 8C). Altogether, these results suggest that the
delay of cell-cycle exit in the shh
2/2 mutant retina is dependent on
the p53 activity inhibiting expression of the CDK inhibitor
p57kip2.
p53 loss rescues amacrine and photoreceptor cells in the
shh
2/2 mutant retina
To address the question whether p53 affects differentiation in
the shh
2/2 mutant, retinal sections of wild-type, shh
2/2 and p53
2/2
shh
2/2 mutant embryos were stained for markers of retinal cell
types. Staining for HuC neuronal marker strongly labelled both
ganglion and amacrine cells in the wild-type (Fig. 9A-a), but only
ganglion cells in the shh
2/2 mutant retina (Fig. 9A-b), whereas in
the p53
2/2shh
2/2 mutant retina, both ganglion and amacrine cells
were labelled (Fig. 9A-c). Consistently, retinal ganglion cells (RGCs)
identified by anti-zn5 staining were present in retinas of all three
genotypes (Fig. 9A-d, e, f). However, amacrine cells labelled by anti-
parvalbumin antibodies in the wild-type retina (Fig. 9A-g), were
absent in the shh
2/2 retina (Fig. 9A-h) and partially rescued in
p53
2/2shh
2/2 embryos (Fig. 9A-i, C). The ratio of area covered by
parvalbumine signal to the total retinal section area in the wild-type
retina (5,19 +/2 1,6%) was significantly different from this ratio in
the p53
2/2shh
2/2 retina (2,03 +/2 0,32%), the efficiency of rescue
being 39% (Fig. 9C). Investigating whether p53 affects differenti-
ation of photoreceptors, it was found that red-green cone and rod
photoreceptors present in the wild-type retina (Fig. 9A-j, m) are
absent in the shh
2/2 retina (Fig. 9A-k, n) and rescued in the
p53
2/2shh
2/2 mutant retina (Fig. 9A-l, o), the rescue being
complete since the relative areas of photoreceptor labeling were
not different between retinas of wild-type and p53
2/2shh
2/2
embryos (Fig. 9C). Mu ¨ller glia, a cell type required to maintain the
retinal environment, was present in the wild-type retina at 72 hpf
(Fig. 9A-p) but nearly absent in both shh
2/2 (Fig. 9A-q) and p53
2/2
shh
2/2 mutant retinas (Fig. 9A-r). Bipolar cells, a retinal cell type
involved in signal transduction during light perception, were
labelled by staining for PKCa in the wild-type retina at 72 hpf
(Fig. 9A-s), but were absent in both shh
2/2 and p53
2/2shh
2/2
mutant retinas (Fig. 9A-t, u). However, at 5 days post fertilization
(dpf), Mu ¨ller glia and bipolar cells appearedin both shh
2/2 (Fig. 9B-
b, e) and p53
2/2shh
2/2 (Fig. 9B-c, f) mutant retinas at similar levels
indicatingthattheirdifferentiationisstronglydelayed intheabsence
of Shh and is not affected by p53 loss. As control, I checked whether
loss of p53 alone affects retinal differentiation and found that
differentiation of retinal cell types in wild-type and p53
2/2 mutant
embryos was comparable (Fig. S3). These results suggest that p53
inhibits differentiation of amacrine cells and photoreceptors in the
shh
2/2 mutant, without affecting differentiation of other cell types.
Discussion
p53 is essential for elevated apoptosis in the absence of
Shh
In vertebrates, Shh signalling is crucial to prevent cell death in
many different contexts, but the mechanism of Shh-mediated
survival regulation is still unclear. To clarify this mechanism, I
focused on apoptosis in the neural tube and retina of the shh
2/2
mutant.
I first examined Bcl2 family gene expression as a potential cause
of apoptosis in the shh
2/2 mutant but haven’t detected any
differences between wild-type and shh
2/2 mutant embryos (Fig.
S1). However, activation of Hh signalling has been shown to
induce expression of bcl2 gene in mouse keratinocytes [14], chick
spinal cord [13] and to maintain Bcl2 gene expression in the mouse
lymphoma cells [53]. Thus, Hh signalling activates Bcl2 expression
in certain contexts, but my results suggest that Shh signaling is not
required for global regulation of Bcl2 family genes during
zebrafish development.
I then show that p53 activates expression of its target genes and
induces apoptosis in the neural tube and retina in the absence of
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2/2 mutant retina during early progenitor proliferation and neurogenesis. pH 3/
DAPI staining of wild-type, shh
2/2 and p53
2/2shh
2/2 retinas was done at 24 hpf (A), 34 hpf (B) and 48 hpf (C). At all stages, the mitotic index in the
shh
2/2 retina was lower than in the wild-type retina, while in the p53
2/2shh
2/2 retina, the mitotic index was comparable to that of the wild-type
retina. (D) Statistical analysis of mitotic indices in wild-type, p53
2/2, shh
2/2 and p53
2/2shh
2/2 retinas at 24 hpf, the indices being comparable in wild-
type (14,9%, SD=2,4%), p53
2/2 (15,3%, SD=2,4%), and p53
2/2shh
2/2 (13,1%, SD=1,9%) embryos and significantly higher than in the shh
2/2 mutant
retina (7,5%, SD=2,3%). (E) Statistical analysis of mitotic indices in the wild-type, p53
2/2, shh
2/2 and p53
2/2shh
2/2 retinas at 34 hpf, comparable in
wild-type (11,8%, SD=1,73%), p53
2/2 (12,02%, SD=1,46%), and p53
2/2shh
2/2 (12,1%, SD=1,9%) retinas, whereas the mitotic index in the shh
2/2
mutant retina was almost twice lower (7%, SD=1,38%). (F) Statistical analysis of mitotic indices in wild-type, shh
2/2 and p53
2/2shh
2/2 retinas at 48
hpf, the indices being comparable in wild-type (11,1%, SD=2%) and p53
2/2shh
2/2 (11,6%, SD=1,54%) embryos and significantly higher than in the
shh
2/2 mutant retina (7,16%, SD=1,25%). Either 8 (D) or 10 (E, F) embryos (2 retinal sections per embryo) were analysed for each genotype and mean
+/2 standard deviation indicated above the bars of mitotic index statistics. Asterisks (***) on top of shh
2/2 mutant bars indicate their significant
statistical differences from other samples (t-test, P-value,0,001).
doi:10.1371/journal.pone.0013549.g007
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2/2 mutant retina. S-phase progression in wild-type, shh
2/2 and p53
2/2shh
2/2
mutants was analysed at 49 and 57 hpg after one-hour labelling with BrdU. Confocal sections stained with anti-BrdU antibodies and DAPI are shown
with the anterior side to the top. (A) Anti-BrdU/DAPI staining of wild-type, shh
2/2 and p53
2/2shh
2/2 mutant retinas at 49 hpf identified a greater
extent of cell-cycle exit (fewer cells labelled) in the wild-type and p53
2/2shh
2/2 mutant than in the shh
2/2 retina. The data from these stainings were
then used for quantification in (D). (B) At 57 hpf in the wild-type retina, BrdU-positive cells were found only in the ciliary marginal zone (CMZ).
However, in the shh
2/2 mutant retina, cells still failed to exit the cell cycle. Like in the wild-type retina, cells of p53
2/2shh
2/2 mutant mostly exited
the cell cycle and proliferative cells were located only in the CMZ. (C) At 38 hpf, p57kip2 expression was at a high level in both wild-type and
p53
2/2shh
2/2 mutant retinas, whereas no p57kip2 was present in the shh
2/2 mutant retina. By contrast, p53 expression was high in the shh
2/2
mutant retina and very low in the wild-type and p53
2/2shh
2/2 mutant retinas. (D) Proportions of BrdU-positive cells (S-phase indices) in wild-type,
shh
2/2 and p53
2/2shh
2/2 retinas at 49 hpf were obtained from confocal sections such as presented in (A). The S-phase indices in wild-type (34,1%,
SD=4,4%) and p53
2/2shh
2/2 (39%, SD=2,8%) were each significantly lower than in the shh
2/2 mutant retina (53,8%, SD=7%) (t-test, P-
value,0,001), the difference between them still being significant (t-test, P-value,0,01). (E) S-phase indices in wild-type, shh
2/2 and p53
2/2shh
2/2
retinas at 57 hpf were obtained from confocal sections such as presented in (B). The S-phase indices in wild-type (17,1%, SD=1,3%) and p53
2/2
shh
2/2 (19%, SD=2,8%) were not significantly different (t-test, P-value.0,05), but were each significantly lower than in the shh
2/2 mutant retina
(55,8%, SD=5%) (t-test, P-value,0,001). Total 10 sections from 5 embryos (2 retinal sections per embryo) were analysed for each genotype and mean
+/2 standard deviation are indicated above the graph bars. Statistical differences were evaluated using t-test with P-values,0,01 (**) or,0,001 (***).
doi:10.1371/journal.pone.0013549.g008
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elevated apoptosis in the shh
2/2 mutant showing that intrinsic
apoptotic pathway is activated. I then determined that the onset of
p53 pathway activation and elevated apoptosis in the shh
2/2
mutant happened at around 10somite stage (Fig. S2). The broad
pattern of p53 target gene expression and apoptosis in the shh
2/2
mutant at 10somite stage argues against cell death due to
differentiation failure, since few cells in the wild-type embryos
express neuronal differentiation marker HuC at this stage [55].
Moreover, early requirement of Shh for cell survival during
development is consistent with the observations that in the neural
tube Hh signaling regulates cell survival independently from and
earlier than its effects on cell fate [13].
PG13p21::nlsEGFP transgenic line faithfully reports
regions with p53 activation
To detect cells that have undergone p53 activation, I
constructed the PG13p21::nlsEGFP transgenic p53 reporter.
Expression of this reporter in shh
2/2 mutant was dependent on
p53, inducible by roscovitine and co-localised with activeCaspase3
labeling in the shh
2/2 mutant at 56 hpf (Fig. 4) suggesting that the
PG13p21::nlsEGFP line is a bona fide p53 reporter.
Expression of p53 reporter in the shh
2/2 mutant retina at 24
hpf was much higher than in the wild-type retina but few apoptotic
cells were detected in both cases (Fig. 5), suggesting that
extraretinal Shh controls p53 activity during early retinal
development before the onset of Shh production in the retina at
28 hpf [49]. However, at 56 hpf, apoptotic cells and p53 reporter-
positive cells are both present in the retina indicating a delay
between initial p53 activation and apoptosis induction in the
shh
2/2 mutant retina probably due to a high level of pro-survival
factors in the early retina. Extraretinal Hh signalling is known to
be required for early retinal patterning, for example, Stenkamp
and Frey (2003) showed that inhibition of Hh signalling from 10
hpf reduces ath5 retinal patterning gene expression stronger than
the same treatments during retinal neurogenesis [56], and Kay
and co-authors (2005) demonstrated that Hh signalling inhibition
from 13 hpf but not from 25 hpf can delay expression of ath5 [57].
Moreover, Masai et al. (2005) found using forskolin, an activator of
PKA, that Hh signalling during 22–26 hpf period is essential for
ath5 expression wave, also highlighting the role of extraretinal Hh
signalling for retinal patterning [36]. My findings are consistent
with these studies, and also implicate extraretinal Hh signalling in
regulation of p53 activity in the retina.
In addition, I observed p53 reporter activation and apoptosis in
the midbrain, hindbrain and spinal cord regions of the neural tube
(Fig. 5), consistent with the previous studies on the survival
function of Shh in these tissues [6,9]. Although p53 reporter
expression but no elevated apoptosis were detected in somites of
the shh
2/2 mutant (Fig. 5D), p53 may mediate apoptosis in the
somites of the shh
2/2 mutant at earlier stages, which would make
the elevated p53 reporter expression fully consistent with the role
of Shh in sclerotome cell survival and myogenic differentiation [7].
Locations of p53 reporter-positive cells in the lateral midbrain are
suggestive of their neural crest origin (Fig. 5), agreeing with the
requirement of Shh for their survival [10]. Taken together, these
results show high expression of the p53 reporter transgenic
reporter in the regions requiring Shh for cell survival and the
advantages of p53 reporter over in situ hybridizations for p53
target genes or antibody stainings against p53 [48] thanks to the
possibility to do live imaging, label specific cell parts and change
the fluorescent protein used for labeling.
Activation of Hh signalling suppresses p53 pathway in
the shh
2/2 mutant
Activation of p53 in the absence of Shh raises the question
whether this elevated p53 activity can be suppressed by Hh
signaling activation. Indeed, Hh signaling activation using
dnPKA-GFP effectively suppressed p53 target gene expression
and apoptosis in the shh
2/2 mutant at 12somite stage (Fig. 6).
While this study was in progress, Abe et al. (2008) have suggested
that Hh signaling regulates stability of p53 by activating Mdm2 in
human cell lines by inducing an unknown Mdm2-activating factor
[18]. Stecca and Altaba (2009) characterized the interaction
between p53 and Gli1, a downstream Hh signalling effector, in
wild-type mouse neural stem cells [19]. These authors found that
Gli1 can suppress p53 activity by up-regulating Mdm2 level. Since
p53 activity can be inhibited by Hh signaling activation in human
cell lines, mouse neural stem cells and zebrafish embryos, the same
mechanism is likely involved.
Concerning p53 regulation, the question is whether Hh signaling
is required for establishment or maintenance of p53 activity control.
Given the localized nature of Shh expression, cells perceiving Shh
signal are unlikely to require persistent Shh signaling for control of
p53activity, butratheronlyduringa certain period ofdevelopment.
Shh is clearly not required to establish control of p53 activity since
p53 can already be activated in the late gastrulation [40], which is
much earlier than the 10somite stage. However, upon the onset of
Shh expression, control of p53 pathway appears to become
dependent on Shh signaling.
Regulation of retinal cell proliferation by p53 in the
shh
2/2 mutant
p53 loss in the shh
2/2 mutant rescues two aspects of retinal
proliferation: cell-cycle exit of retinal cell progenitors (Fig. 8) and
Figure 9. p53 loss rescues amacrine and photoreceptor cells in the shh
2/2 mutant retina. Differentiation of retinal cell types was assessed
using specific antibodies (A, B). The sections are oriented with their anterior side to the top. All sections were stained with phalloidin-Alexa568 (A, a–
u; B, a–f) to visualize retinal lamination. Staining for HuC neuronal antigen labelled ganglion and amacrine cells in the wild-type retina (A, a), ganglion
and very few amacrine cells in the shh
2/2 mutant retina (A, b). In the p53
2/2shh
2/2 retina, however, labelling of both ganglion cells and amacrine
cells was partially restored (A, c). Ganglion cells labelled by an anti-zn5 antibody were present in comparable numbers in wild-type (A, d), shh
2/2
mutant (A, e) and p53
2/2shh
2/2 mutant retinas (A, f). Amacrine cells labelled by anti-parvalbumine antibody were present in the wild-type retina (A,
g), absent in the shh
2/2 mutant (A, h) and partially rescued in the p53
2/2shh
2/2 mutant retina (A, i). Red-green double cones (zpr1 antibody
labelling) and rod photoreceptors (zpr3 antibody labeling) were present in the wild-type retina (A, j, m), absent in the shh
2/2 mutant retina (A, k, n)
and rescued in the p53
2/2shh
2/2 mutant retina (A, l, o). Staining for glutamine synthetase (GS) labelled Mu ¨ller glia cells in wild-type embryos (A, p). In
both shh
2/2 and p53
2/2shh
2/2 retinas, very few Mu ¨ller glia were present (A, q, r). Bipolar cells were labelled in the wild-type retina by anti-PKCa
antibody staining (A, s), but absent in shh
2/2 and p53
2/2shh
2/2 retinas (A, t, u). At 5 dpf, Mu ¨ller glia and bipolar cells were detected in shh
2/2 and
p53
2/2shh
2/2 retinas (B, b,c,e,f) but in lower numbers than in the wild-type retina (B, a,d). All stainings were performed on at least 6 embryos for each
genotype and representative images are shown. (C) Quantitation of rescue of amacrine cells (parvalbumine labelling), red-green double cone (zpr1)
and rod photoreceptors (zpr3) in the p53
2/2shh
2/2 mutant retina by plotting ratios of segmented area for each staining to the total retina area.
Amacrine cells occupy a significantly larger relative area in the wild-type than in the p53
2/2shh
2/2 mutant retina (* on top of the bars, t-test, P-
value,0,05), whereas relative areas of both types of photoreceptors are not significantly different in wild-type and p53
2/2shh
2/2 mutant retinas.
doi:10.1371/journal.pone.0013549.g009
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Moreover, expression of the cyclin-dependent kinase inhibitor
p57kip2 is induced in the p53
2/2shh
2/2 mutant retina (Fig. 8C)
arguing for normal cell-cycle exit. A normal mitotic index in the
p53
2/2shh
2/2 mutant retina before neurogenesis (24 hpf) is likely
to result from lack of p53-activated cell cycle inhibitory gene
expression, while the rescue of cell-cycle exit and normal mitotic
indices in the retina during neurogenesis may be due to both lack
of cell-cycle inhibitor expression and more mitoses of differenti-
ating cells upon cell-cycle exit. Previous studies of cell-cycle exit in
the zebrafish retina [35,36] showed that Hh signalling is essential
for p57kip2 expression in the retina. I support this conclusion and
propose that Shh signalling regulates retinal expression of p57kip2
by controlling activity of p53.
p53-mediated Notch1 expression may be responsible for failure
of shh
2/2 mutant embryos to express p57kip2. Notch1 is a p53
target in human keratinocytes [58] and myeloid and lymphoid
cells [59]. Moreover, bioinformatic analyses suggest that Gli2 can
prevent p53 from activating Notch1 gene expression, which could
be a connection between p53, Hh and Notch pathways [60]. In
zebrafish, Notch1 homologs are also likely to be p53 targets since
they contain optimal p53 binding sites (unpublished results). Notch
signaling inhibits p57kip2 expression during zebrafish neural tube
development [61], during mouse pancreas development [62], in
the adult mouse intestinal crypts [63] and during eye lense
development in the mouse [64]. Whether p53 blocks retinal cell-
cycle exit in the absence of shh by activating Notch signalling will
undoubtedly be uncovered by future studies.
Coordinate regulation of cell cycle, cell survival and
differentiation in the retina
This study shows that p53 inhibits generation of amacrine and
photoreceptor cells in the shh
2/2 mutant retina, raising a question
whether p53 loss is essential only for their survival or also for
differentiation. My data suggest that in the shh
2/2 mutant, p53 loss
is essential both for survival and cell-cycle exit of retinal
progenitors, which must occur before cells can differentiate. By
contrast, differentiation of ganglion cells, bipolar and Mu ¨ller glia
cells the shh
2/2 mutant retina is not affected by p53 suggesting
that Shh signalling promotes retinal differentiation not only by
controlling p53 activity but also by other p53-independent
mechanisms.
In the retinal progenitor cells, differentiation decisions are
coupled to regulation of cell cycle. This study has shown that p53
affects both retinal cell cycle and differentiation phenotypes in the
shh
2/2 mutant embryos implicating p53 pathway in coupling of
cell cycle regulation and differentiation in the retina. Other studies
identified some of the mechanisms coordinating cell cycle and
differentiation decisions in the retina. Retinoblastoma 1 (Rb1)
promotes retinal differentiation through inhibition of both E2f1
and E2f3a and its loss in the developing mouse retina leads to
ectopic proliferation and elevated apoptosis rescued by E2f1 loss
[65]. There is a functional analogy between Rb1-E2f and Shh-p53
interactions, Rb1 and Shh being required for proper cell cycle
regulation, differentiation and control of E2f factors and p53,
respectively. By contrast, in the postnatal mouse retina, Rb has
been proposed to promote rod photoreceptor differentiation
through activation of Nrl transcription factor [66]. CDK inhibitors
(CDKI) are essential for cell-cycle exit of retinal progenitors, but
are known regulate their differentiation through cell-cycle
independent mechanisms, the importance of CDKI-mediated cell
cycle inhibition still being unclear (reviewed in [67]). Studies by
Ohnuma and colleagues showed that p27Xic1, a Xenopus CDK
inhibitor, promotes generation of Mu ¨ller glia at the expense of
bipolar cells [68]. In this context, p27Xic1 interacts functionally
with Notch/Delta signalling and proneural genes such as Xath5 to
precisely regulate neurogenesis sequence [69,70]. Consistent with
the lack of amacrine cells in the shh
2/2 mutant, mouse p57Kip2 is
involved in development of a subset of amacrine cells [71].
Regulation of cell death is another powerful mechanism known
to shape organs. Several studies of zebrafish mutants addressed
whether suppression of p53-mediated apoptosis affects retinal
differentiation. In mutants of DNA polymerase delta 1 subunit
(pold1), suppression of apoptosis in the retina by p53 knockdown
rescues eye size and morphology [72] and in the primase1 mutant,
p53 knockdown led to the rescue of amacrine cell and
photoreceptor differentiation [73]. By contrast, p53 knockdown
in chromatin assembly factor 1b mutant didn’t improve retinal or
cartilage differentiation [74], since this gene is required for both
cell survival and differentiation of most cell types. Rescue of
amacrine cells and photoreceptors by p53 loss in the shh
2/2
mutant retina is similar to p53 knockdown results in pold1 and
primase1 mutants, but Shh likely affects differentiation by
regulating p53 activity and through other mechanisms, whereas
mutations of pold1 or primase1 were proposed to induce genotoxic
damage. Other studies identified context-dependence of p53
effects on differentiation, for example, p53 promotes differentia-
tion in mouse embryonic stem cells after DNA damage by
decreasing Nanog expression [75] and reduces spontaneous
differentiation of human stem cells [76].
Conclusions
These results identify p53 pathway as the essential mediator of
the elevated apoptosis in the developing nervous system and retina
in the absence of Shh in zebrafish. I also find that Shh signalling
promotes cell survival in this context by inhibiting p53 pathway. In
the retina, Shh controls p53 to regulate both cell survival and
proliferation, since in the shh mutant loss of p53 suppresses elevated
apoptosis, leads to normal mitotic indices in the retina and rescues
cell-cycle exit. Control of p53 by Shh is also essential for
differentiation of some amacrine cells and photoreceptors.
Materials and Methods
Fish stocks, maintenance, identification and care
Wild-type WIK, sonic-you
t4 [77] and p53
zdf1 [44] heterozygous
fish were used. Fish were maintained according to standard
protocols. Embryos were grown in E3 embryo medium at 28uC
with or without the addition of 0.003% 1-phenyl-2-thiourea
(Sigma) to inhibit pigmentation. Staging was performed according
to hours post-fertilization (hpf) [78]. Identification of p53 genotype
was performed according to a published protocol [44]. Fin clips
were obtained by anesthesizing adult fish in 0.02% Tricaine and
then cutting small pieces of the caudal fin. All DNA samples for
identification were prepared as described previously [79]. sonic-
you
t4 mutants were identified by their curled body shape and U-
shaped somites.
Morpholino and mRNA microinjection procedures
p53 morpholino (GCGCCATTGCTTTGCAAGAATTG, [42])
and four-mismatch control p53 morpholino (GCA CCA TCG
CTT GGC AAG CAT TG) [72] were purchased from Gene
Tools and injected into 1-cell stage at 0.5 mM. To make RNA for
over-expression experiments, required pCS2+ vectors were linear-
ised and transcribed using mMessage mMachine SP6 (Ambion, cat
# AM1340). The following plasmids were used to prepare
RNA for microinjections: pCS2+dnPKA-GFP [51], pCS2+EGFP,
pCS2+EGFP-bcl2 [54], pCS2+FA Transposase (Tol2kit).
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Human CDKN1A/p21 2.4 kb promoter was amplified from
RPCI-11 Human BAC clone (Imagenes, RPCIB753F15397Q)
using the following primers:
HindIII_p21prom_for AAGCTTGGGCACTCTTGTCCCC-
CAGG
BamHI_p21prom_rev GGATCCCTGACTTCGGCAGCTGC-
TCA
The resulting PCR product was TOPO-cloned into pCR2.1
(Invitrogen) and then subcloned into the p5E-MCS vector using
HindIII and BamHI restriction sites to make p5E-p21 vector.
PG13 enhancer (13 copies of an optimal p53 binding site
CCTGCCTGGACTTGCCTGG) [46] was ordered from GEN-
EART AG (custom product). The synthetic PG13 fragment
contained KpnI and HindIII restriction sites for directional
cloning into p5E-p21. Insertion of PG13 into p5E-p21 resulted
into the final 59-entry vector p5E-PG13p21. To generate
pDestCG2-PG13p21::nlsEGFP-polyA, p5E-PG13p21 was recom-
bined with pME-nlsEGFP, p3E-polyA and pDestCG2 vectors
(Tol2kit, [47]). The construct was then injected into wild-type
embryos, which were raised to adulthood and identified as
transgenic founders.
In situ hybridisation and probe synthesis
RNA in situ hybridisations were performed according to Jowett
(2001) [80]. Probes were made using Roche DIG RNA Labeling
Kit (Cat # 11175025910). The fragments of p53, puma, p21, bcl2,
mcl1a, mcl1b were cloned into pCR4 vector (Invitrogen) using the
primers listed in Table 1. Plasmids containing cyclinG1 cDNA
(pCMV-SPORT6.1-cyclinG1 (Imagenes)), mdm2 cDNA (pME-
18S-FL3 – mdm2 (Imagenes)), bax1 cDNA (pME-18S-FL3 – bax1
(Imagenes)) and bcl2l (pDNR-LIB-bcl2l (Imagenes)) were used for
making templates for in vitro transcription using primers listed in
Table 1. Probes for p57 and patched1 were made using previously
published plasmids [35,81].
BrdU labelling
Embryos were anesthesized with 0.02% Tricaine and injected
with a small drop (5–10 nl) of 10 mM 5-Bromodeoxyuridine
(BrdU) into the yolk sac. After injection, embryos were allowed to
develop for a required period of time and fixed in PFA for analysis.
BrdU-labeled embryo were then cryosectioned and the sections
were dried, washed in PBST (PBS + 0.1% Tween20 (Sigma, cat#
P9416)), incubated in 2N HCl for 10 minutes at 23uC and then
transferred to 37uC for another 30 minutes and washed again in
PBST. Anti-BrdU staining was done as described in the next
section of Materials and Methods, the sections finally being stained
with 20 mg/ml of DAPI. Quantification of BrdU-positive nuclei
was done using ‘‘Colocalization Threshold’’ analysis of BrdU and
DAPI signals and ‘‘Cell Counter’’ plugins of Fiji software (http://
pacific.mpi-cbg.de) as described below.
Immunohistochemical methods
Antibody stainings were done on cryosections as described
before [35]. The following antibodies were used: anti-zn5, anti-
zpr1, anti-zpr3 at 1:100 dilution (Developmental Studies Hybrid-
oma Bank), anti-parvalbumine – Chemicon (MAB1572) at 1:200
dilution, anti-GAD67 – Chemicon (AB5862P) at 1:100 dilution,
anti-glutamine synthetase – BD Biosciences (cat# 610517) at
1:500 dilution, anti-PKCa – Santa Cruz Biotechnology (sc-208) at
1:100 dilution, anti-HuC – Molecular Probes (A-21271), anti-GFP
– Molecular Probes, Invitrogen (A11122) at 1:200 dilution, anti-
BrdU – Sigma (cat# B8434) at 1:100 dilution, anti-pH3-S10 –
Abcam (ab5176-100) at 1:400 dilution, anti-activeCaspase3 – BD
Pharmingen (cat# 557035) at 1:200 dilution. Secondary anti-
mouse Alexa Fluor 488 antibody (1:400) (Invitrogen, cat#
A11001), anti-rabbit Alexa Fluor 488 (1:400) (Invitrogen, cat#
A-11008) and anti-rabbit Alexa Fluor 594 (1:400) (Invitrogen,
cat# A-11012) were diluted in blocking solution and incubated on
the sections for 2 hours. To label actin structures, Alexa Fluor 568
labeled phalloidin (Invitrogen, A12380) was diluted at 1:400 in
Table 1. Primers used to amplify cDNA fragments.
Primer_ _name Sequence Template for PCR
mcl1a_for tatggctttgagtttggattttagg cDNA
mcl1a_rev gcattgatagccattggc cDNA
mcl1b_for gagaagaagaaaaaatgtagagttg cDNA
mcl1b_rev agcacttcgaaaaggaaaa cDNA
bcl2l_for tggataaccgtattaccgcc pDNR-LIB-bcl2l (ZFIN)
T3_bcl2l_rev cgcgcaattaaccctcactaaagcactagtcataccaggatc pDNR-LIB-bcl2l (ZFIN)
bcl2_for gcgcgtttctatcgtgattt cDNA
bcl2_rev agcatgtgtgcacgtgtttt cDNA
bax1_for tgtacggaagtgttacttctgctc pME18S-FL3-bax1(ZFIN)
T3_bax1_rev ggatccattaaccctcactaaagggaaggccgcgacctgcagctc pME18S-FL3-bax1(ZFIN)
p53_for gaatccccaaaactccacgc cDNA
p53_rev ccaaaaagagcaaaactccc cDNA
pME_for attaaccctcactaaaggctgctcctcagtggatgttgcctttac pME18S-FL3-mdm2 (Imagenes)
T7_pME_rev taatacgactcactataggcaggttcagggggaggtgtgg pME18S-FL3-mdm2 (Imagenes)
puma_for aacaccgctttatatcccct cDNA
puma_rev tgtgttcatctgaggccgtg cDNA
p21_for tcaggtgttcctcagctcct cDNA
p21_rev cggaataaacggtgtcgtct cDNA
doi:10.1371/journal.pone.0013549.t001
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were taken using Leica SP2 confocal microscope and processed
using Adobe Creative Suite CS4.
Co-localisation analysis
Co-localisation was analysed using ‘‘Colocalisation Threshold’’
plugin of Fiji software. The plugin takes two images and outputs
several statistics including percent of co-localised pixels relative to
total pixels in each of the co-localising channels and an image,
where pixels present in both images are white.
Apoptosis assays
ApopTag staining was performed using Chemicon ApopTag
Peroxidase in situ apoptosis detection kit (Cat # S7100) as
described before [74]. TUNEL staining on cryosections was
performed as described before [35] using TUNEL-TMR-Red kit
(Roche, cat # 1966006001).
qPCR and semi-quantitative PCR assays
RNA from whole embryos or embryo heads was purified using
RNeasy kit (Qiagen, cat# 74104) and cDNA samples were
prepared using Quantitect Reverse Transcription Kit (Qiagen,
cat# 205311) and used for quantitative real-time PCR after 20-
fold dilution. SYBRH Green PCR Master Mix (Applied Biosys-
tems, cat# 4309155) was used to prepare qPCR reactions, which
were run on the ABI7500 qPCR machine. Primers used for qPCR
assays and appropriate references are listed in Table 2. Semi-
quantitative PCR for full-length p53, its D113 isoform and b-actin
transcripts was performed essentially as described before [38].
Counting procedure
TUNEL-positive, DAPI-stained nuclei and pH 3-labelled cells
were counted manually using the Cell Counter plugin of ImageJ,
which allows labelling already counted objects and automatically
records their number.
Image quantification
Image quantification in Figs. 2A-B and Fig.9 was done using Fiji
software. To quantify the area of particular signal in an image, raw
RGB images were split into channels, and single channel images
were processed to remove irrelevant parts of the image (select and
Edit Clear Outside). The processed images were thresholded, the
threshold being the same for all images in an experiment and
manually chosen for optimal segmentation of the signal.
Thresholded images were then segmented using the Analyze
Particles plugin (Analyze Analyze Particles), which outputs the
area of the segmented signal.
Statistical analyses
The differences of cell proportions and counts were statistically
evaluated using Student’s t-test in Microsoft Excel 2007. qPCR
data were initially processed using the SDS1.2 software from
Applied Biosystems to obtain Ct values, that is the amplification
cycle number at which a reaction reaches a certain threshold of
expression. Relative gene expression was calculated using the
DDCt method ([82]) assuming equal amplification efficiencies. Ct
values of all samples were normalised by reference gene expression
and by average wild-type gene expression before being converted
to fold expression differences. Student’s t-test was then applied to
fold expression differences (p,0.05 was set as a significance level).
Statistical significance of embryo proportions in the Hedgehog
signalling activation experiment (Fig. 6) was determined using
Fisher’s exact test using fisher.test function from R language
environment (R version 2.9.0).
Supporting Information
Figure S1 Expression of anti-apoptotic Bcl2 family genes in
shh2/2 mutant versus wild-type zebrafish embryos at 24 hpf. In
situ whole-mount analysis of bcl2, bcl2l, mcl1a and mcl1b
expression in shh2/2 mutant and wild-type embryos at 24 hpf.
Found at: doi:10.1371/journal.pone.0013549.s001 (3.22 MB TIF)
Figure S2 Onset of increased p53 expression and apoptosis in
shh2/2 mutant occurs during somitogenesis. p53 in situ was used
to identify time points with activated p53 protein (A, B, E, F, I, J,
M, N, R, S, V, W). ApopTag staining was used as an assay for
apoptosis (C, D, G, H, K, L, P, Q, T, U, X, Y). The following
stages were analysed 1somite (A–D), 6somite (E–H), 8somite (I–L),
10somite (M–Q), 12somite (R–U), 14somite (V–Y). At early stages
it was not possible to identify the embryos (wild-type or shh2/2).
From 10somite stage, shh2/2 mutant embryos could be
identified based on their p53 expression and ApopTag staining
because they made one quarter of the batch. The stainings were
repeated two times and 40 embryos were analysed for each
staining.
Found at: doi:10.1371/journal.pone.0013549.s002 (5.97 MB TIF)
Figure S3 Normal differentiation of retinal cell types in p532/2
mutant. Antibody staining of retinal cryosections from p532/2
mutant embryos at 72 hpf. Anterior side of the sections is to the top
of the images. Phalloidin-Alexa568 was used to label actin
structures. The images show normal differentiation of ganglion
cells (zn-5), amacrine cells (GAD67 and parvalbumin), Mu ¨ller glia
(glutamine synthetase (GS)), bipolar cells (Protein kinase C a
(PKCa)) and photoreceptors (zpr1 and zpr3).
Found at: doi:10.1371/journal.pone.0013549.s003 (3.13 MB TIF)
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